160 related articles for article (PubMed ID: 19036017)
1. Strongly increased levels of fibrinogen elastase degradation products in patients with ischemic stroke.
de Lau LM; Cheung EY; Kluft C; Leebeek FW; Meijer P; Laterveer R; Dippel DW; de Maat MP
Br J Haematol; 2008 Dec; 143(5):734-7. PubMed ID: 19036017
[TBL] [Abstract][Full Text] [Related]
2. Antithrombin III associated with fibrinogen predicts the risk of cerebral ischemic stroke.
Meng R; Li ZY; Ji X; Ding Y; Meng S; Wang X
Clin Neurol Neurosurg; 2011 Jun; 113(5):380-6. PubMed ID: 21316837
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients.
Rallidis LS; Vikelis M; Panagiotakos DB; Liakos GK; Krania E; Kremastinos DT
Acta Neurol Scand; 2008 Jun; 117(6):415-20. PubMed ID: 18093263
[TBL] [Abstract][Full Text] [Related]
4. Persistent hyperfibrinogenemia in acute ischemic stroke / transient ischemic attack (TIA).
Shenhar-Tsarfaty S; Ben Assayag E; Bova I; Shopin L; Cohen M; Berliner S; Shapira I; Bornstein NM
Thromb Haemost; 2008 Jan; 99(1):169-73. PubMed ID: 18217150
[TBL] [Abstract][Full Text] [Related]
5. Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke.
Welsh P; Barber M; Langhorne P; Rumley A; Lowe GD; Stott DJ
Cerebrovasc Dis; 2009; 27(3):247-53. PubMed ID: 19176958
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein and fibrinogen in acute stroke patients with and without sleep apnea.
Dziewas R; Ritter M; Kruger L; Berger S; Langer C; Kraus J; Dittrich R; Schabitz WR; Ringelstein EB; Young P
Cerebrovasc Dis; 2007; 24(5):412-7. PubMed ID: 17878721
[TBL] [Abstract][Full Text] [Related]
7. D-dimer, magnetic resonance imaging diffusion-weighted imaging, and ABCD2 score for transient ischemic attack risk stratification.
Cucchiara BL; Messe SR; Sansing L; MacKenzie L; Taylor RA; Pacelli J; Shah Q; Pollak ES; Kasner SE
J Stroke Cerebrovasc Dis; 2009; 18(5):367-73. PubMed ID: 19717021
[TBL] [Abstract][Full Text] [Related]
8. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Purdy G; Lawrie AS; Watt H; Brown MM; Machin SJ
Br J Haematol; 2004 Jun; 125(6):777-87. PubMed ID: 15180868
[TBL] [Abstract][Full Text] [Related]
9. Effect of age and glycaemic control on the association between fibrinogen and risk of acute coronary events after transient ischaemic attack or stroke.
Howard SC; Algra A; Rothwell PM;
Cerebrovasc Dis; 2008; 25(1-2):136-43. PubMed ID: 18073467
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical discrimination of leukocyte elastase from plasmic degradation products of fibrinogen.
Plow EF; Gramse M; Havemann K
J Lab Clin Med; 1983 Dec; 102(6):858-69. PubMed ID: 6227673
[TBL] [Abstract][Full Text] [Related]
11. Markers of inflammation in cerebral ischemia.
Bartosik-Psujek H; Belniak E; Stelmasiak Z
Neurol Sci; 2003 Nov; 24(4):279-80. PubMed ID: 14658049
[TBL] [Abstract][Full Text] [Related]
12. Wide-range C-reactive protein efficacy in acute ischemic stroke patients.
Shenhar-Tsarfaty S; Ben Assayag E; Bova I; Vered Y; Berliner S; Rogowski O; Shapira I; Bornstein NM
Acta Neurol Scand; 2006 Jul; 114(1):29-32. PubMed ID: 16774624
[TBL] [Abstract][Full Text] [Related]
13. Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events.
Yang DT; Flanders MM; Kim H; Rodgers GM
Am J Clin Pathol; 2006 Sep; 126(3):411-5. PubMed ID: 16880142
[TBL] [Abstract][Full Text] [Related]
14. Role of serum fibrinogen in patients of ischemic cerebrovascular disease.
Beg M; Nizami A; Singhal KC; Mohammed J; Gupta A; Azfar SF
Nepal Med Coll J; 2007 Jun; 9(2):88-92. PubMed ID: 17899955
[TBL] [Abstract][Full Text] [Related]
15. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
[TBL] [Abstract][Full Text] [Related]
16. Elevated visfatin/pre-B-cell colony-enhancing factor plasma concentration in ischemic stroke.
Lu LF; Yang SS; Wang CP; Hung WC; Yu TH; Chiu CA; Chung FM; Shin SJ; Lee YJ
J Stroke Cerebrovasc Dis; 2009; 18(5):354-9. PubMed ID: 19717018
[TBL] [Abstract][Full Text] [Related]
17. NR2 antibodies: risk assessment of transient ischemic attack (TIA)/stroke in patients with history of isolated and multiple cerebrovascular events.
Weissman JD; Khunteev GA; Heath R; Dambinova SA
J Neurol Sci; 2011 Jan; 300(1-2):97-102. PubMed ID: 20934192
[TBL] [Abstract][Full Text] [Related]
18. Hemostatic abnormalities and leukocyte activation caused by infection in patients with malignant lymphoma during chemotherapy.
Kamikura Y; Wada H; Sase T; Yamaguchi M; Kaneko T; Sakaguchi A; Abe Y; Nishioka J; Nobori T; Shiku H
Thromb Res; 2006; 117(6):671-9. PubMed ID: 16026816
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma glutamate in stroke patients might be linked to altered platelet release and uptake.
Aliprandi A; Longoni M; Stanzani L; Tremolizzo L; Vaccaro M; Begni B; Galimberti G; Garofolo R; Ferrarese C
J Cereb Blood Flow Metab; 2005 Apr; 25(4):513-9. PubMed ID: 15660099
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer.
Kono T; Ohtsuki T; Hosomi N; Takeda I; Aoki S; Sueda Y; Ishihara K; Nakamura T; Yamawaki T; Matsumoto M
Geriatr Gerontol Int; 2012 Jul; 12(3):468-74. PubMed ID: 22233138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
